Trials / Completed
CompletedNCT02094430
Human Fibrinogen Concentrate (FGTW) in Pediatric Patients With Congenital Fibrinogen Deficiency
Clinical Pharmacology, Efficacy and Safety Study of FGTW in Paediatric Patients With Severe Congenital Fibrinogen Deficiency
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 16 (actual)
- Sponsor
- Laboratoire français de Fractionnement et de Biotechnologies · Industry
- Sex
- All
- Age
- 12 Years
- Healthy volunteers
- Not accepted
Summary
The aim of the study is to evaluate clinical pharmacology, efficacy and safety of FGTW in pediatric patients with congenital fibrinogen deficiency.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | biological: human fibrinogen concentrate |
Timeline
- Start date
- 2014-01-01
- Primary completion
- 2015-12-01
- Completion
- 2015-12-01
- First posted
- 2014-03-21
- Last updated
- 2016-02-12
Locations
4 sites across 4 countries: France, Lebanon, Morocco, Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT02094430. Inclusion in this directory is not an endorsement.